by Amy Berger | Jul 7, 2021 | News, Publications and Press
IITRI is proud to share the promising news from multiple sponsors of COVID-19 in vitro and in vivo studies. Links below to press releases and recent publications. Congrats all! New IITRI Co-Author Publication: Scalable live-attenuated SARS-CoV-2 vaccine...
by Amy Berger | Aug 5, 2020 | News, Publications and Press
IITRI is proud to share the promising news of one of our partners, Moleculin! Our team here at IITRI was contracted to perform additional in vitro testing of their drug candidate (WP1122) for antiviral effects against SARS-CoV-2. We used growth medium that more...
by iitri | Sep 29, 2016 | News, Publications and Press
IITRI announces the recent award of three major new programs by the Biomedical Advanced Research and Development Authority (BARDA) valued at more than $4.7 M. The programs are for the development and/or evaluation of cutting edge technologies and agents to control...
by iitri | Jul 5, 2016 | News, Publications and Press
The National Cancer Institute’s Division of Cancer Treatment and Diagnosis (DCTD) has awarded IITRI $29.8 million for two major 5-year new programs. The DCTD supports many programs that facilitate the development of cancer therapeutics from the bench to the patient,...
by iitri | Sep 26, 2015 | News, Publications and Press
IIT Research Institute has been awarded a contract for up to $9 million for preclinical services to support the National Cancer Institute (NCI) Preclinical PREVENT Cancer Program – Toxicology and Pharmacology Testing. This NCI program was initiated to bring new...
by iitri | Sep 1, 2014 | News, Publications and Press
IITRI offers a wide range of bioanalytical services for the detection and quantification of both small molecule and biologic drug candidates from human clinical trial samples. Two recent publications highlight our experience in determining drug and hormone...
Recent Comments